| Period Ending: |
LTM
(Last Twelve Months) |
2021 12-31 |
2020 12-31 |
|---|---|---|---|
| Report Filing | 2022-11-14 | 2022-03-31 | 2020-12-31 |
| Revenue | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 |
| Operating Expenses | 2.03 | 0.778 | 0 |
| Research & Development | 0 | 0 | 0 |
| Selling, General and Administrative | 1.73 | 0.637 | 0 |
| Other Operating Expenses | 0.298 | 0.141 | 0 |
| Operating Income | -2.03 | -0.778 | -0 |
| Net Non-Operating Interest | 3.03 | 2.83 | 0 |
| Interest Income | 0.855 | 0.011 | 0 |
| Interest Expense | -2.17 | -2.82 | 0 |
| Equity & Other Income/(Expense) | 5.1 | -0.011 | 0 |
| Income Before Tax | 6.1 | 2.04 | -0 |
| Income Tax Expense | -5.35 | -2.82 | 0 |
| Income Attributable to Non-Controlling Interest | -0 | 0 | 0 |
| Net Income | 11.45 | 4.87 | -0 |
| Depreciation and Amortization | 8.13 | 2.82 | 0.206 |
| EBITDA | 6.1 | 2.04 | 0.206 |
| Earnings Per Share (EPS) | 0.704 | 0.3 | -0 |
| Diluted Earnings Per Share | 0.704 | 0.3 | -0 |
| Weighted Average Shares Outstanding | 16.25 | 16.49 | 16.74 |
| Diluted Weighted Average Shares Outstanding | 16.25 | 16.49 | 16.74 |
